行情

TMBR

TMBR

Timber Pharmaceuticals
AMEX

实时行情|Nasdaq Last Sale

0.2450
-0.0148
-5.70%
盘后: 0.2570 +0.012 +4.90% 18:42 05/18 EDT
开盘
0.2912
昨收
0.2598
最高
0.2912
最低
0.2450
成交量
30.41万
成交额
1.28万
52周最高
1.410
52周最低
0.2306
市值
1,560.13万
市盈率(TTM)
-0.9031
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解TMBR最新的财务预测,通过TMBR每股收益,每股净资产,每股现金流等数据分析Timber Pharmaceuticals近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
0.00%买入
100.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测TMBR价格均价为2.250,最高价位2.250,最低价为2.250。
最高2.250
均价2.250
最低2.250
现价0.2450
EPS
实际EPS
预期EPS
-1.07-0.80-0.54-0.27
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q2 2021
机构持股
总机构数: 16
机构持股: 88.08万
持股比例: 1.38%
总股本: 6,367.88万
类型机构数股数
增持
5
17.28万
建仓
5
7.86万
减持
5
55.71万
平仓
7
1.04万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-3.24%
制药与医学研究
-2.06%
高管信息
Chairman/President/Chief Executive Officer/Director
John Koconis
Chief Financial Officer/Executive Vice President/Treasurer
Joseph Lucchese
Executive Vice President
Alan Mendelsohn
Director
Zachary Rome
Independent Director
David Cohen
Independent Director
Lubor Gaal
Independent Director
Gianluca Pirozzi
Independent Director
Edward Sitar
暂无数据
暂无数据
TMBR 简况
Timber Pharmaceuticals, Inc. (Timber) is a clinical-stage biopharmaceutical company. It is focused on development of treatments for orphan dermatologic diseases. It Is also focused on developing non-systemic treatments for dermatologic diseases, including congenital ichthyosis, facial angiofibromas (FAs) in tuberous sclerosis complex (TSC), and scleroderma. The Company's pipeline programs include TMB-001, TMB-002 and TMB-003. TMB-001 is topical formulation of isotretinoin, evaluated in a Phase II b clinical trial for the treatment of congenital ichthyosis (CI), a genetic keratinization. TMB-002 is a topical formulation of rapamycin, evaluated in a Phase II b clinical trial for the treatment of FAs in TSC, a multisystem genetic disorder resulting in the growth of hamartomas in multiple organs. TMB-003 is a formulation of sitaxsentan in the preclinical development for the treatment of scleroderma, a rare connective tissue disorder characterized by abnormal thickening of the skin.

微牛提供Timber Pharmaceuticals Inc(AMEX-TMBR)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的TMBR股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易TMBR股票基本功能。